Skip to main content

4 Result(s)

within M. J. Terrier-Lacombe Remove this filter

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Brain tumours under the age of three. The price of survival

Include preview-only content

  1. Article

    Open Access

    No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

    CPT-11 (irinotecan) is a DNA-topoisomerase I inhibitor with preclinical activity against neuroblastoma (NB) xenografts. The aim was to establish in vivo an NB xenograft resistant to CPT-11 in order to study the r...

    L Calvet, A Santos, A Valent, M-J Terrier-Lacombe, P Opolon… in British Journal of Cancer (2004)

    Download PDF (370 KB) View Article

  2. Article

    Open Access

    Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy

    The aim of this study was to describe the incidence, clinical and histological characteristics, treatment and long-term follow-up of bilateral germ-cell tumours (BGCT) of the testis in order to determine in wh...

    Ch Theodore, M J Terrier-Lacombe, A Laplanche, G Benoit… in British Journal of Cancer (2004)

    Download PDF (114 KB) View Article

  3. Article

    Open Access

    Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children

    A series of 23 children with primitive neuroectodermal tumours (PNET) were analysed with comparative genomic hybridization (CGH). Multiple chromosomal imbalances have been detected in 20 patients. The most fre...

    H Avet-Loiseau, A-M Vénuat, M-J Terrier-Lacombe… in British Journal of Cancer (1999)

    Download PDF (341 KB)

  4. Article

    Open Access

    Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

    High-dose busulphan-containing chemotherapy regimens have shown high response rates in children with relapsed or refractory neuroblastoma, Ewing’s sarcoma and medulloblastoma. However, the anti-tumour activity...

    I Boland, G Vassal, J Morizet, M-J Terrier-Lacombe… in British Journal of Cancer (1999)

    Download PDF (219 KB)